Venture Capital Investors

Zymo Research

Zymo Research is focused on investing in high-tech companies.

Venture Investor Overview

Contact Information

Background Information

Overview

Since 1994, Zymo Research has been led by a vision to have a positive impact in the biomedical field and to contribute to the greater good of humanity. Our innovative sample collection reagents, kits and devices have been used all over the World; even to protect biological samples from space with NASA. Most recently, DNA/RNA Shield was awarded the first 510(k)-cleared transport medium for COVID-19 testing and COVID-19 variant sequencing service. Start your good science today by upgrading the quality and preservation of your samples with our sample collection kits, devices and reagents.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/10/2023

Transaction History

Our records indicate that Zymo Research invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Vice President

Marc Eden

        

Chief Executive Officer

Xiyu Jia

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Zymo Research has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Zylun Global | Zynik Capital

Share this article

About Our Venture Capital Investor Database

Our data comes from VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary